Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia.

Mathew L ThakurVivek S TomarEmma DaleLeonard G GomellaCharalambos SolomidesOleksandr KolesnikovScott W KeithHector T NavarroOlivia DahlgrenMichael ChagaEdouard J Trabulsi

Published in: BJUI compass (2024)

VPAC assay may contribute extensively for BPH diagnosis and warrant continued investigation.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
multidrug resistant
high throughput
cancer therapy
copy number
gene expression
drug delivery